LYRA - Lyra Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Lyra Therapeutics, Inc. Common Stock
IPO Date: May 1, 2020
Sector: Healthcare
Industry: Biotech
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.26 | 9.02%
Avg Daily Range (30 D): $0.09 | 468.71%
Avg Daily Range (90 D): $0.08 | 122.90%
Institutional Daily Volume
Avg Daily Volume: .51M
Avg Daily Volume (30 D): M
Avg Daily Volume (90 D): .01M
Trade Size
Avg Trade Size (Sh.): 322
Avg Trade Size (Sh.) (30 D): 429
Avg Trade Size (Sh.) (90 D): 879
Institutional Trades
Total Institutional Trades: 56
Avg Institutional Trade: $1.96M
Avg Institutional Trade (30 D): $.65M
Avg Institutional Trade (90 D): $.65M
Avg Institutional Trade Volume: .42M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.16M
Avg Closing Trade (30 D): $.65M
Avg Closing Trade (90 D): $.65M
Avg Closing Volume: 772.22K
 
News
Jun 2, 2025 @ 11:00 AM
Lyra Therapeutics Reports Positive Results from th...
Source: N/A
May 7, 2025 @ 11:00 AM
Lyra Therapeutics to Present 52-week Extension Sta...
Source: N/A
Oct 15, 2024 @ 11:00 AM
Lyra Therapeutics Fully Enrolls Pivotal Phase 3 EN...
Source: N/A
Sep 27, 2024 @ 11:00 AM
Lyra Therapeutics to Present Study Results for LYR...
Source: Lyra Therapeutics, Inc.
May 21, 2024 @ 1:14 PM
Lyra Therapeutics Announces Cost-Cutting Measures...
Source: Lyra Therapeutics
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-18.62 $-3.77 $-18.62
Diluted EPS $-18.62 $-3.77 $-18.62
Revenue $.4M $.01M $.4M
Gross Profit
Net Income / Loss $-28.92M $-6.95M $-28.92M
Operating Income / Loss $-31.02M $-7.12M $-31.02M
Cost of Revenue
Net Cash Flow $-24.68M $-6.16M $-24.68M
PE Ratio    
Splits
May 28, 2025 1:50